ALT5 Sigma Corporation (NASDAQ:ALTS - Get Free Report) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 510,700 shares, a growth of 23.0% from the May 15th total of 415,100 shares. Based on an average daily volume of 193,900 shares, the short-interest ratio is currently 2.6 days. Approximately 3.0% of the shares of the stock are sold short.
ALT5 Sigma Trading Up 3.4%
NASDAQ ALTS traded up $0.31 during trading hours on Friday, reaching $9.47. 384,076 shares of the stock traded hands, compared to its average volume of 230,192. The stock has a 50 day simple moving average of $7.36 and a two-hundred day simple moving average of $5.85. ALT5 Sigma has a 1 year low of $1.29 and a 1 year high of $10.95. The company has a current ratio of 0.83, a quick ratio of 0.83 and a debt-to-equity ratio of 1.26.
ALT5 Sigma Company Profile
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
See Also
Before you consider ALT5 Sigma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ALT5 Sigma wasn't on the list.
While ALT5 Sigma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
